Post-heart transplant complications
- PMID: 24996612
- DOI: 10.1016/j.ccc.2014.03.005
Post-heart transplant complications
Abstract
Managing patients after heart transplantation is challenging, since these patients have unique clinical complications (associated with the immunosuppressive therapy and cardiac allograft rejection) together with atypical clinical presentations for infection and systemic inflammatory response syndrome. Survival rates have improved substantially with the use of new immunosuppressive drugs. High vigilance, early diagnosis, and appropriate intervention for allograft-related and non-allograft-related syndromes with significant morbidity and mortality are the keys to long-term survival of patients after transplantation.
Keywords: Complications; Heart transplant; Immunosuppression; Rejection.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.J Heart Lung Transplant. 1998 Apr;17(4):374-82. J Heart Lung Transplant. 1998. PMID: 9588582
-
Neurologic aspects of heart transplantation.Handb Clin Neurol. 2014;121:1229-36. doi: 10.1016/B978-0-7020-4088-7.00082-1. Handb Clin Neurol. 2014. PMID: 24365414 Review.
-
Managing complications in heart transplant recipients. Improved techniques and medications increase survival rates.J Crit Illn. 1993 Jun;8(6):678-89. J Crit Illn. 1993. PMID: 10148766 Review.
-
State of the art in paediatric heart transplantation: the Berlin experience.Eur J Cardiothorac Surg. 2013 Feb;43(2):258-67. doi: 10.1093/ejcts/ezs588. Epub 2012 Nov 25. Eur J Cardiothorac Surg. 2013. PMID: 23184909
-
Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.J Heart Lung Transplant. 1996 Feb;15(2):124-35. J Heart Lung Transplant. 1996. PMID: 8672515
Cited by
-
Advancements in Heart Transplantation: Donor-Derived Cell-Free DNA as Next-Generation Biomarker.Cureus. 2024 Feb 11;16(2):e54018. doi: 10.7759/cureus.54018. eCollection 2024 Feb. Cureus. 2024. PMID: 38476807 Free PMC article. Review.
-
Mitigating Cross-Species Viral Infections in Xenotransplantation: Progress, Strategies, and Clinical Outlook.Cell Transplant. 2024 Jan-Dec;33:9636897241226849. doi: 10.1177/09636897241226849. Cell Transplant. 2024. PMID: 38258759 Free PMC article. Review.
-
Effect of preoperative pulmonary artery pressure on the prognosis of end-stage heart failure patients after heart transplantation.J Cardiothorac Surg. 2023 Apr 17;18(1):154. doi: 10.1186/s13019-023-02253-x. J Cardiothorac Surg. 2023. PMID: 37069699 Free PMC article.
-
Identifying Patients With a Higher Potential for Recovery Post Left Ventricular Assist Device: A Single-Center Experience.Ochsner J. 2021 Winter;21(4):341-346. doi: 10.31486/toj.20.0160. Ochsner J. 2021. PMID: 34984047 Free PMC article.
-
Adherence to immunosuppression in adult heart transplant recipients: A systematic review.Transplant Rev (Orlando). 2021 Dec;35(4):100651. doi: 10.1016/j.trre.2021.100651. Epub 2021 Sep 20. Transplant Rev (Orlando). 2021. PMID: 34592641 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
